Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IXEKIZUMAB vs JUXTAPID: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IXEKIZUMAB vs JUXTAPID: Safety Overview

Metric IXEKIZUMAB JUXTAPID
Total FAERS Reports 33,680 179
Deaths Reported 470 2
Death Rate 1.4% 1.1%
Hospitalizations 2,424 13
Average Patient Age 52.0 yrs 58.0 yrs
% Female Patients 60.2% N/A
Manufacturer Eli Lilly and Company N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A